Overactive bladder-18 years - Part I

Detalhes bibliográficos
Autor(a) principal: Truzzi, Jose Carlos [UNIFESP]
Data de Publicação: 2016
Outros Autores: Gomes, Cristiano Mendes, Bezerra, Carlos A., Plata, Ivan Mauricio, Campos, Jose, Garrido, Gustavo Luis, Almeida, Fernando G. [UNIFESP], Averbeck, Marcio Augusto, Fornari, Alexandre, Salazar, Anibal, Dell'Oro, Arturo, Cintra, Caio, Ricetto Sacomani, Carlos Alberto, Tapia, Juan Pablo, Brambila, Eduardo, Longo, Emilio Miguel, Rocha, Flavio Trigo, Coutinho, Francisco, Favre, Gabriel, Garcia, Jose Antonio, Castano, Juan, Reyes, Miguel, Leyton, Rodrigo Eugenio, Ferreira, Ruiter Silva, Duran, Sergio, Lopez, Vanda, Reges, Ricardo
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: https://repositorio.unifesp.br/handle/11600/57828
http://dx.doi.org/10.1590/S1677-5538.IBJU.2015.0365
Resumo: Overactive bladder syndrome is one of the lower urinary tract dysfunctions with the highest number of scientific publications over the past two decades. This shows the growing interest in better understanding this syndrome, which gathers symptoms of urinary urgency and increased daytime and nighttime voiding frequency, with or without urinary incontinence and results in a negative impact on the quality of life of approximately one out of six individuals - including both genders and almost all age groups. The possibility of establishing the diagnosis just from clinical data made patients' access to specialized care easier. Physiotherapy resources have been incorporated into the urological daily practice. A number of more selective antimuscarinic drugs with consequent lower adverse event rates were released. Recently, a new class of oral drugs, beta-adrenergic agonists has become part of the armamentarium for Overactive Bladder. Botulinum toxin injections in the bladder and sacral neuromodulation are routine modalities of treatment for refractory cases. During the 1st Latin-American Consultation on Overactive Bladder, a comprehensive review of the literature related to the evolution of the concept, epidemiology, diagnosis, and management was conducted. This text corresponds to the first part of the review Overactive Bladder 18-years.
id UFSP_84036c0270c2be2e744908d829056332
oai_identifier_str oai:repositorio.unifesp.br:11600/57828
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Truzzi, Jose Carlos [UNIFESP]Gomes, Cristiano MendesBezerra, Carlos A.Plata, Ivan MauricioCampos, JoseGarrido, Gustavo LuisAlmeida, Fernando G. [UNIFESP]Averbeck, Marcio AugustoFornari, AlexandreSalazar, AnibalDell'Oro, ArturoCintra, CaioRicetto Sacomani, Carlos AlbertoTapia, Juan PabloBrambila, EduardoLongo, Emilio MiguelRocha, Flavio TrigoCoutinho, FranciscoFavre, GabrielGarcia, Jose AntonioCastano, JuanReyes, MiguelLeyton, Rodrigo EugenioFerreira, Ruiter SilvaDuran, SergioLopez, VandaReges, Ricardo2020-08-21T16:59:59Z2020-08-21T16:59:59Z2016International Braz J Urol. Rio De Janeiro, v. 42, n. 2, p. 188-198, 2016.1677-5538https://repositorio.unifesp.br/handle/11600/57828http://dx.doi.org/10.1590/S1677-5538.IBJU.2015.0365S1677-55382016000200188-en.pdfS1677-5538201600020018810.1590/S1677-5538.IBJU.2015.0365WOS:000375604900005Overactive bladder syndrome is one of the lower urinary tract dysfunctions with the highest number of scientific publications over the past two decades. This shows the growing interest in better understanding this syndrome, which gathers symptoms of urinary urgency and increased daytime and nighttime voiding frequency, with or without urinary incontinence and results in a negative impact on the quality of life of approximately one out of six individuals - including both genders and almost all age groups. The possibility of establishing the diagnosis just from clinical data made patients' access to specialized care easier. Physiotherapy resources have been incorporated into the urological daily practice. A number of more selective antimuscarinic drugs with consequent lower adverse event rates were released. Recently, a new class of oral drugs, beta-adrenergic agonists has become part of the armamentarium for Overactive Bladder. Botulinum toxin injections in the bladder and sacral neuromodulation are routine modalities of treatment for refractory cases. During the 1st Latin-American Consultation on Overactive Bladder, a comprehensive review of the literature related to the evolution of the concept, epidemiology, diagnosis, and management was conducted. This text corresponds to the first part of the review Overactive Bladder 18-years.Univ Fed Sao Paulo, EPM, Rua Dr Oscar Monteiro Barros 617-141, BR-05641010 Sao Paulo, SP, BrazilUniv Sao Paulo, Dept Urol, BR-05508 Sao Paulo, SP, BrazilFac Med ABC, Dept Urol, Sao Paulo, SP, BrazilUniv Los Andes, Dept Urol, Bogota, ColombiaEscuela Med, Dept Urol, Mexico City, DF, MexicoHosp Clin Jose San Martin, Catedra Urol, Buenos Aires, DF, ArgentinaMae de Deus Ctr Hosp, Dept Urol, Porto Alegre, RS, BrazilUniv Fed Ciencias Saude Porto Alegre, Porto Alegre, RS, BrazilAC Camargo Hosp, Dept Urol, Sao Paulo, BrazilHosp Clin Fuerza Area Chile, Santiago, ChileInst Mexicano Seguro Social, Mexico City, DF, MexicoHosp Souza Aguiar, Dept Urol, Rio De Janeiro, RJ, BrazilComplejo Med Policial Churruca Visca, Serv Urol, Buenos Aires, DF, ArgentinaCtr Policlin Valencia Vina, Valencia, VenezuelaHosp Pablo Tobon Uribe, Medellin, ColombiaClin Indisa, Serv Urol, Providencia, ChileCtr Reabilitacao & Readaptacao Dr Henriqe Santill, Goiania, Go, BrazilHosp Univ Caracas, Serv Urol, Caracas, VenezuelaUniv Fed Ceara, Div Urol, Fortaleza, Ceara, BrazilUniv Fed Sao Paulo, EPM, Rua Dr Oscar Monteiro Barros 617-141, BR-05641010 Sao Paulo, SP, BrazilWeb of Science188-198engBrazilian Soc UrolInternational Braz J UrolOveractive BladderMuscarinic AntagonistsBeta-adrenergic agonistsBotulinum ToxinSacral neuromodulationUrodynamicsOveractive bladder-18 years - Part Iinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleRio De Janeiro422info:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESPORIGINALS1677-55382016000200188-en.pdfapplication/pdf110532${dspace.ui.url}/bitstream/11600/57828/1/S1677-55382016000200188-en.pdfecb07c032bc7df173150023822e7bee9MD51open accessTEXTS1677-55382016000200188-en.pdf.txtS1677-55382016000200188-en.pdf.txtExtracted texttext/plain50353${dspace.ui.url}/bitstream/11600/57828/2/S1677-55382016000200188-en.pdf.txt17bd162aaae9509750e9e9d9e730ae27MD52open accessTHUMBNAILS1677-55382016000200188-en.pdf.jpgS1677-55382016000200188-en.pdf.jpgIM Thumbnailimage/jpeg6343${dspace.ui.url}/bitstream/11600/57828/4/S1677-55382016000200188-en.pdf.jpg523b8be3b842dd0c72c63a8593f5c6c3MD54open access11600/578282022-07-31 19:53:57.737open accessoai:repositorio.unifesp.br:11600/57828Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestopendoar:34652022-07-31T22:53:57Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.en.fl_str_mv Overactive bladder-18 years - Part I
title Overactive bladder-18 years - Part I
spellingShingle Overactive bladder-18 years - Part I
Truzzi, Jose Carlos [UNIFESP]
Overactive Bladder
Muscarinic Antagonists
Beta-adrenergic agonists
Botulinum Toxin
Sacral neuromodulation
Urodynamics
title_short Overactive bladder-18 years - Part I
title_full Overactive bladder-18 years - Part I
title_fullStr Overactive bladder-18 years - Part I
title_full_unstemmed Overactive bladder-18 years - Part I
title_sort Overactive bladder-18 years - Part I
author Truzzi, Jose Carlos [UNIFESP]
author_facet Truzzi, Jose Carlos [UNIFESP]
Gomes, Cristiano Mendes
Bezerra, Carlos A.
Plata, Ivan Mauricio
Campos, Jose
Garrido, Gustavo Luis
Almeida, Fernando G. [UNIFESP]
Averbeck, Marcio Augusto
Fornari, Alexandre
Salazar, Anibal
Dell'Oro, Arturo
Cintra, Caio
Ricetto Sacomani, Carlos Alberto
Tapia, Juan Pablo
Brambila, Eduardo
Longo, Emilio Miguel
Rocha, Flavio Trigo
Coutinho, Francisco
Favre, Gabriel
Garcia, Jose Antonio
Castano, Juan
Reyes, Miguel
Leyton, Rodrigo Eugenio
Ferreira, Ruiter Silva
Duran, Sergio
Lopez, Vanda
Reges, Ricardo
author_role author
author2 Gomes, Cristiano Mendes
Bezerra, Carlos A.
Plata, Ivan Mauricio
Campos, Jose
Garrido, Gustavo Luis
Almeida, Fernando G. [UNIFESP]
Averbeck, Marcio Augusto
Fornari, Alexandre
Salazar, Anibal
Dell'Oro, Arturo
Cintra, Caio
Ricetto Sacomani, Carlos Alberto
Tapia, Juan Pablo
Brambila, Eduardo
Longo, Emilio Miguel
Rocha, Flavio Trigo
Coutinho, Francisco
Favre, Gabriel
Garcia, Jose Antonio
Castano, Juan
Reyes, Miguel
Leyton, Rodrigo Eugenio
Ferreira, Ruiter Silva
Duran, Sergio
Lopez, Vanda
Reges, Ricardo
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Truzzi, Jose Carlos [UNIFESP]
Gomes, Cristiano Mendes
Bezerra, Carlos A.
Plata, Ivan Mauricio
Campos, Jose
Garrido, Gustavo Luis
Almeida, Fernando G. [UNIFESP]
Averbeck, Marcio Augusto
Fornari, Alexandre
Salazar, Anibal
Dell'Oro, Arturo
Cintra, Caio
Ricetto Sacomani, Carlos Alberto
Tapia, Juan Pablo
Brambila, Eduardo
Longo, Emilio Miguel
Rocha, Flavio Trigo
Coutinho, Francisco
Favre, Gabriel
Garcia, Jose Antonio
Castano, Juan
Reyes, Miguel
Leyton, Rodrigo Eugenio
Ferreira, Ruiter Silva
Duran, Sergio
Lopez, Vanda
Reges, Ricardo
dc.subject.eng.fl_str_mv Overactive Bladder
Muscarinic Antagonists
Beta-adrenergic agonists
Botulinum Toxin
Sacral neuromodulation
Urodynamics
topic Overactive Bladder
Muscarinic Antagonists
Beta-adrenergic agonists
Botulinum Toxin
Sacral neuromodulation
Urodynamics
description Overactive bladder syndrome is one of the lower urinary tract dysfunctions with the highest number of scientific publications over the past two decades. This shows the growing interest in better understanding this syndrome, which gathers symptoms of urinary urgency and increased daytime and nighttime voiding frequency, with or without urinary incontinence and results in a negative impact on the quality of life of approximately one out of six individuals - including both genders and almost all age groups. The possibility of establishing the diagnosis just from clinical data made patients' access to specialized care easier. Physiotherapy resources have been incorporated into the urological daily practice. A number of more selective antimuscarinic drugs with consequent lower adverse event rates were released. Recently, a new class of oral drugs, beta-adrenergic agonists has become part of the armamentarium for Overactive Bladder. Botulinum toxin injections in the bladder and sacral neuromodulation are routine modalities of treatment for refractory cases. During the 1st Latin-American Consultation on Overactive Bladder, a comprehensive review of the literature related to the evolution of the concept, epidemiology, diagnosis, and management was conducted. This text corresponds to the first part of the review Overactive Bladder 18-years.
publishDate 2016
dc.date.issued.fl_str_mv 2016
dc.date.accessioned.fl_str_mv 2020-08-21T16:59:59Z
dc.date.available.fl_str_mv 2020-08-21T16:59:59Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv International Braz J Urol. Rio De Janeiro, v. 42, n. 2, p. 188-198, 2016.
dc.identifier.uri.fl_str_mv https://repositorio.unifesp.br/handle/11600/57828
http://dx.doi.org/10.1590/S1677-5538.IBJU.2015.0365
dc.identifier.issn.none.fl_str_mv 1677-5538
dc.identifier.file.none.fl_str_mv S1677-55382016000200188-en.pdf
dc.identifier.scielo.none.fl_str_mv S1677-55382016000200188
dc.identifier.doi.none.fl_str_mv 10.1590/S1677-5538.IBJU.2015.0365
dc.identifier.wos.none.fl_str_mv WOS:000375604900005
identifier_str_mv International Braz J Urol. Rio De Janeiro, v. 42, n. 2, p. 188-198, 2016.
1677-5538
S1677-55382016000200188-en.pdf
S1677-55382016000200188
10.1590/S1677-5538.IBJU.2015.0365
WOS:000375604900005
url https://repositorio.unifesp.br/handle/11600/57828
http://dx.doi.org/10.1590/S1677-5538.IBJU.2015.0365
dc.language.iso.fl_str_mv eng
language eng
dc.relation.ispartof.none.fl_str_mv International Braz J Urol
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 188-198
dc.coverage.none.fl_str_mv Rio De Janeiro
dc.publisher.none.fl_str_mv Brazilian Soc Urol
publisher.none.fl_str_mv Brazilian Soc Urol
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
bitstream.url.fl_str_mv ${dspace.ui.url}/bitstream/11600/57828/1/S1677-55382016000200188-en.pdf
${dspace.ui.url}/bitstream/11600/57828/2/S1677-55382016000200188-en.pdf.txt
${dspace.ui.url}/bitstream/11600/57828/4/S1677-55382016000200188-en.pdf.jpg
bitstream.checksum.fl_str_mv ecb07c032bc7df173150023822e7bee9
17bd162aaae9509750e9e9d9e730ae27
523b8be3b842dd0c72c63a8593f5c6c3
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv
_version_ 1802764117380956160